CARDINAL HEALTH, INC. for CARDINAL HEALTH INC

Health Issues HCR

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3159 (119th), S. 3822 (119th), H.R. 5031 (119th), H.R. 3164 (119th), S. 2426 (119th), H.R. 4299 (119th)

Manufacturing MAN

Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Trade (domestic/foreign) TRD

Issues related to tariffs, trade, and U.S. trade policy.

Contacted: White House Office; Commerce, Dept of (DOC); Food & Drug Administration (FDA); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Tariff (miscellaneous tariff bills) TAR

Issues related to tariffs, trade, and U.S. trade policy.

Contacted: SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Treasury, Dept of; White House Office